Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line

Oncology Reports

Volumn 29, Issue 1, 2013, Pages 394-400

  Zhou, Yuan ^a   Wang, Han Dong ^a   Zhu, Lin ^a   Cong, Zi Xiang ^a   Li, Ning ^b   Ji, Xiang Jun ^a   Pan, Hao ^a   Wang, Jia Wei ^a   Li, Wan Chun ^a  

^a NANJING UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Autophagy; Chemotherapy; Glioblastoma multiforme; NF E2 related factor 2; Temozolomide

Indexed keywords

CELL PROTEIN; PROTEIN LC3B II; TEMOZOLOMIDE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; CANCER INHIBITION; CELL VACUOLE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE SILENCING; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; AUTOPHAGY; BLOTTING, WESTERN; BRAIN NEOPLASMS; DACARBAZINE; DOWN-REGULATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GLIOMA; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; NF-E2-RELATED FACTOR 2; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 84872831679     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2115     Document Type: Article

References (41)

1. Germano IM, Emdad L, Qadeer ZA, Binello E and Uzzaman M: Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas. Cancer Gene Ther 17: 664-674, 2010.
2. Ulasov IV, Sonabend AM, Nandi S, Khramtsov A, Han Y and Lesniak MS: Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo. Br J Cancer 100: 1154-1164, 2009.
3. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New Engl J Med 352: 987-996, 2005.
4. Jiang H, White EJ, Conrad C, Gomez-Manzano C and Fueyo J: Autophagy pathways in glioblastoma. Method Enzymol 453: 273-286, 2009.
5. Pan H, Wang H, Zhu L, Mao L, Qiao L and Su X: The Role of Nrf2 in migration and invasion of human glioma cell U251. World Neurosurg: Nov 7, 2011 (Epub ahead of print).
6. Zhang DD: The Nrf2-Keap1-ARE signaling pathway: The regulation and dual function of Nrf2 in cancer. Antioxid Redox Signal 13: 1623-1626, 2010.
7. Lau A, Villeneuve NF, Sun Z, Wong PK and Zhang DD: Dual roles of Nrf2 in cancer. Pharmacol Res 58: 262-270, 2008.
8. Akhdar H, Loyer P, Rauch C, Corlu A, Guillouzo A and Morel F: Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells. Eur J Cancer 45: 2219-2227, 2009.
9. Zhang J, Stevens MF and Bradshaw TD: Temozolomide: mechanisms of action, repair and resistance. Curr Mol Pharmacol 5: 102-114, 2012.
10. Wang XJ, Sun Z, Villeneuve NF, et al: Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29: 1235-1243, 2008.
11. Levine B, Mizushima N and Virgin HW: Autophagy in immunity and inflammation. Nature 469: 323-335, 2011.
12. Klionsky DJ, Abeliovich H, Agostinis P, et al: Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4: 151-175, 2008.
13. Mathew R and White E: Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night. Curr Opin Genet Dev 21: 113-119, 2011.
14. Jeon SH, Kim SH, Kim Y, et al: The tricyclic antidepressant imipramine induces autophagic cell death in U-87MG glioma cells. Biochem Biophys Res Commun 413: 311-317, 2011.
15. Park EJ, Choi KS and Kwon TK: ß-Lapachone-induced reactive oxygen species (ROS) generation mediates autophagic cell death in glioma U87 MG cells. Chem Biol Interact 189: 37-44, 2011.
16. Jiang H, Gomez-Manzano C, Aoki H, et al: Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst 99: 1410-1414, 2007.
17. Kaza N, Kohli L and Roth KA: Autophagy in brain tumors: a new target for therapeutic intervention. Brain Pathol 22: 89-98, 2012.
18. Jakubowicz-Gil J, Langner E and Rzeski W: Kinetic studies of the effects of Temodal and quercetin on astrocytoma cells. Pharmacol Rep 63: 403-416, 2011.
19. Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y and Kondo S: Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 11: 448-457, 2004.
20. Natsumeda M, Aoki H, Miyahara H, et al: Induction of autophagy in temozolomide treated malignant gliomas. Neuropathology 31: 486-493, 2011.
21. Katayama M, Kawaguchi T, Berger MS and Pieper RO: DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ 14: 548-558, 2007.
22. Kato T, Natsume A, Toda H, et al: Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells. Gene Ther 17: 1363-1371, 2010.
23. Voss V, Senft C, Lang V, et al: The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma. Mol Cancer Res 8: 1002-1016, 2010.
24. Lefranc F: Glioblastomas are resistant to apoptosis but less resistant to the autophagic process. Bull Mem Acad R Med Belg 162: 331-338, 2007 (In French).
25. Stepkowski TM and Kruszewski MK: Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis. Free Radic Biol Med 50: 1186-1195, 2011.
26. Gao S, Yang XJ, Zhang WG, Ji YW and Pan Q: Mechanism of thalidomide to enhance cytotoxicity of temozolomide in U251-MG glioma cells in vitro. Chin Med J 122: 1260-1266, 2009.
27. Klingelhoeffer C, Kammerer U, Koospal M, et al: Natural resistance to ascorbic acid induced oxidative stress is mainly mediated by catalase activity in human cancer cells and catalase-silencing sensitizes to oxidative stress. BMC Complement Altern Med 12: 61, 2012.
28. Lau AT, Wang Y and Chiu JF: Reactive oxygen species: current knowledge and applications in cancer research and therapeutic. J Cell Biochem 104: 657-667, 2008.
29. Bjorkoy G, Lamark T, Brech A, et al: p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171: 603-614, 2005.
30. Mizushima N and Yoshimori T: How to interpret LC3 immunoblotting. Autophagy 3: 542-545, 2007.
31. Aoki H, Kondo Y, Aldape K, et al: Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3. Autophagy 4: 467-475, 2008.
32. Lin CJ, Lee CC, Shih YL, et al: Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. Free Radic Biol Med 52: 377-391, 2012.
33. Chen H-Y and White E: Role of autophagy in cancer prevention. Cancer Prev Res 4: 973-983, 2011.
34. Moreau K, Luo S and Rubinsztein DC: Cytoprotective roles for autophagy. Curr Opin Cell Biol 22: 206-211, 2010.
35. Rao VA, Klein SR, Bonar SJ, et al: The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinone. J Biol Chem 285: 34447-34459, 2010.
36. Pan Q, Yang XJ, Wang HM, et al: Chemoresistance to temozolomide in human glioma cell line U251 is associated with increased activity of O6-methylguanine-DNA methyltransferase and can be overcome by metronomic temozolomide regimen. Cell Biochem Biophys 62: 185-191, 2012.
37. Cho JM, Manandhar S, Lee HR, Park HM and Kwak MK: Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance. Cancer Lett 260: 96-108, 2008.
38. Nezis IP and Stenmark H: p62 at the interface of autophagy, oxidative stress signaling, and cancer. Antioxid Redox Signal 17: 786-793, 2012.
39. Inami Y, Waguri S, Sakamoto A, et al: Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J Cell Biol 193: 275-284, 2011.
40. Jain A, Lamark T, Sjottem E, et al: p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 285: 22576-22591, 2010.
41. Komatsu M, Kurokawa H, Waguri S, et al: The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 12: 213-223, 2010.